Aktieanalyser från populära analyshus

17 Mar 08:18

Polarcool: Kyligare kvartal än väntat - Mangold Insight Analys

PolarCool

17 Mar 07:20

North Media: Negative EV, allocation policy needs revision - ABG

Q4 EBIT and guidance pre-announced, portfolio return better Conference call failed to ease three key...

Acarix: Further confirmation of CADScor by the Global Cardiovascular Awards - Redeye

Fiskars: Transitions to SaaS-based DTC services and takes EUR 27m impairment - Nordea

Fiskars transitions to SaaS-based Direct-to-Consumer (DTC) services and takes EUR 27m impairment to ...

Fiskars

Analys | Analysguiden

14 Mar 14:39

Kentima: Tillbaka till tillväxt 2025 - Analysguiden

Kentima

14 Mar 13:08

North Media: Q4 investment return better than expected - ABG

Q4: Headline figures pre-announced last week... ...

Atria: Launches planning phase to modernise its food factory in Nurmo - Nordea

Biovica: Expanding market reach and increased sales - Redeye

Biovica continouse to increase 12m rolling IVD test sales in Q3 of SEK 0.

Biovica

14 Mar 07:23

Nolato: CMD recap: back to earnings growth focus - ABG

Elicera Therapeutics: Outcome of warrant program announced - Redeye

Redeye gives a short comment on the positive outcome of Elicera’s TO2 warrant program.

Elicera Therapeutics

13 Mar 16:59

Tangiamo: Transformativt år bäddar för större vinster framgent - Analyst Group

Biovica Q3: Expanding market reach and increased sales support - Redeye

Biovica records IVD test sales in Q3 of SEK 0.74m (460% above Q3 last year) and total sales of SEK 2...

Biovica

Analys | Analysguiden

13 Mar 10:39

SyntheticMR: Försäljningstillväxt i fokus - Analysguiden

JonDeTech Sensors: Kostnadseffektiviseringar ger effekt - Mangold Insight Analys

JonDeTechs personalkostnader var 12 procent lägre än Mangolds prognos och övriga kostnader var 4 pro...

JonDeTech Sensors

13 Mar 08:53

Nolato: New targets ahead of CMD - ABG

Neola Medical: Directed issue - Redeye

Redeye comments on Neola Medical’s directed issue, raising approximately SEK20m.

Neola Medical

13 Mar 07:20

Clavister: We raise estimates on good activity - ABG

Clavister

12 Mar 15:39

Kommentar på Cedergrenskas initiativ för att optimera kapitalstrukturen, extra utdelning samt återköpsprogram - Analyst Group

Cedergrenska AB (”Cedergrenska” eller ”Koncernen”) meddelade den 12 mars 2025 att Koncernen har ingå...

Dala Energi: Intends to become a majority shareholder in DalaVind - Redeye

M.O.B.A. Network: Rebound in sight - Redeye

Redeye resumes its coverage of M.O.B.A. Network. We currently see an attractive entry point, followi...

RaySearch Laboratories: An accelerating niche leader - Redeye

RaySearch Laboratories

Analys | Mangold

12 Mar 08:38

XP Chemistries: Godkänd analysmetod - Mangold Insight Analys

I februari 2025 bad EFSA (Europeiska myndigheten för livsmedelssäkerhet) om ytterligare tid för slut...

CapMan: Capital Markets Day key impressions - Nordea

CapMan

12 Mar 07:16

Qben Infra: Riding the wave of infra spending - ABG

Messy quarter, but 2025 guidance firm & in line with ABGSCe Minor estimate changes, EBITA -1-2% on '...

Cindrigo: Lower risk with first revenues, Germany secured and LSE Main Market listing - Emergers

11 Mar 17:14

Analyst Group kommenterar Refine Groups avyttring av Ecomm och indirekt Gasoltuben

Refine Group AB (”Refine”, ”Koncernen” eller ”Bolaget”) meddelade den 10 mars år 2025 att Bolaget ha...

Refine Group

11 Mar 15:29

EcoRub: Tar kliv mot bredare internationell kommersialisering - Analyst Group

EcoRub

Analys | Analysguiden

11 Mar 11:16

Soltech Energy: Starkt kassaflöde trots utmanande marknad - Analysguiden

Soltech Energy navigerar en utmanande marknad men ser samtidigt starka framtidsmöjligheter.

Cantargia breast cancer study fully recruited - Edison

Cantargia